171 related articles for article (PubMed ID: 29070520)
1. Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FRα/ERK1/2/TSLC1 pathway.
Liu Z; Jin X; Pi W; Liu S
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29070520
[TBL] [Abstract][Full Text] [Related]
2. Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.
Luo S; Huang G; Wang Z; Wan Z; Chen H; Liao D; Chen C; Li H; Li B; Chen L; Huang Z; He Z
Int J Clin Exp Pathol; 2015; 8(9):9990-10001. PubMed ID: 26617707
[TBL] [Abstract][Full Text] [Related]
3. Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug.
Jittreetat T; Shin YS; Hwang HS; Lee BS; Kim YS; Sannikorn P; Kim CH
Yonsei Med J; 2016 May; 57(3):588-98. PubMed ID: 26996556
[TBL] [Abstract][Full Text] [Related]
4. Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway.
Hsin CH; Huang CC; Chen PN; Hsieh YS; Yang SF; Ho YT; Lin CW
Am J Chin Med; 2017; 45(7):1557-1572. PubMed ID: 28946771
[TBL] [Abstract][Full Text] [Related]
5. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
[TBL] [Abstract][Full Text] [Related]
6. Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression.
Peng X; Zhang Q; Zeng Y; Li J; Wang L; Ai P
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1173-84. PubMed ID: 26546460
[TBL] [Abstract][Full Text] [Related]
7. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Cao Q; Zhang J; Zhang T
Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
[TBL] [Abstract][Full Text] [Related]
8. Morusin Suppresses Cancer Cell Invasion and MMP-2 Expression through ERK Signaling in Human Nasopharyngeal Carcinoma.
Huang CC; Wang PH; Lu YT; Yang JS; Yang SF; Ho YT; Lin CW; Hsin CH
Molecules; 2020 Oct; 25(20):. PubMed ID: 33096744
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
Wang JY; Jin X; Li XF
Oncol Res; 2018 Jan; 26(1):95-101. PubMed ID: 28409556
[TBL] [Abstract][Full Text] [Related]
10. Folic acid inhibits COLO-205 colon cancer cell proliferation through activating the FRα/c-SRC/ERK1/2/NFκB/TP53 pathway: in vitro and in vivo studies.
Kuo CT; Chang C; Lee WS
Sci Rep; 2015 Jun; 5():11187. PubMed ID: 26056802
[TBL] [Abstract][Full Text] [Related]
11. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
13. KAI1 overexpression promotes apoptosis and inhibits proliferation, cell cycle, migration, and invasion in nasopharyngeal carcinoma cells.
Guo Z; Wang Y; Yang J; Zhong J; Liu X; Xu M
Am J Otolaryngol; 2017; 38(5):511-517. PubMed ID: 28583320
[TBL] [Abstract][Full Text] [Related]
14. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract][Full Text] [Related]
15. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
16. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
17. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C
Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819
[TBL] [Abstract][Full Text] [Related]
18. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
19. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid A suppresses MMP-2 expression and restrains cancer cell invasion through ERK signaling in human nasopharyngeal carcinoma.
Chuang CY; Ho YC; Lin CW; Yang WE; Yu YL; Tsai MC; Yang SF; Su SC
J Ethnopharmacol; 2020 Apr; 252():112601. PubMed ID: 31981746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
